Combined high dose caspofungin and liposomal amphotericin B for the treatment of azole-resistant cerebral aspergillosis

Antimicrob Agents Chemother. 2021 Jul 12:AAC0047421. doi: 10.1128/AAC.00474-21. Online ahead of print.


The prevalence of azole-resistant aspergillosis is increasing and represents a public health issue in some countries, with an excess mortality of 25% (1).….

PMID:34252300 | DOI:10.1128/AAC.00474-21